Table 3 Composite clinical outcomes
DD (N = 42) | Normal (N = 125) | P value | |
|---|---|---|---|
Follow-up periods | 28.4 ± 13.9 | 32.3 ± 12.4 | 0.107 |
Composite clinical outcomes | 13 (31.0%) | 4 (3.2%) | < 0.001 |
Cardiac death, n(%) | 0 (0%) | 2 (1.6%) | 0.464 |
Hospitalization HF, n(%) | 13 (31.0%) | 2 (1.6%) | < 0.001 |